key: cord-0743097-zamux01j
authors: Kuzmina, Alona; Atari, Nofar; Ottolenghi, Aner; Korovin, Dina; lass, Ido Cohen; Rosental, Benyamin; Rosenberg, Elli; Mandelboim, Michal; Taube, Ran
title: P681 mutations within the polybasic motif of spike dictate fusogenicity and syncytia formation of SARS CoV-2 variants
date: 2022-04-27
journal: bioRxiv
DOI: 10.1101/2022.04.26.489630
sha: 3936189a4a475afdbd135a269aadf7b956bb58ac
doc_id: 743097
cord_uid: zamux01j

The rapid spread and dominance of the Omicron SARS-CoV-2 over its Delta variant has posed severe global challenges. While extensive research on the role of the Receptor Binding Domain on viral infectivity and vaccine sensitivity has been documented, the role of the spike 681PRRAR/SV687 polybasic motif is less clear. Here we monitored infectivity and vaccine sensitivity of Omicron SARS-CoV-2 pseudovirus against sera samples that were drawn four months post administration of the third dose of BNT162b2 mRNA vaccine. Our findings show that relative to Wuhan-Hu and Delta SARS-CoV-2, Omicron displayed enhanced infectivity and a sharp decline in its sensitivity to vaccine-induced neutralizing antibodies. Furthermore, while the spike proteins form Wuhan-Hu (P681), Omicron (H681) and BA.2 (H681) pseudoviruses modestly promoted cell fusion and syncytia formation, Delta spike (P681R) displayed enhanced fusogenic activity and syncytia formation capability. Live-viruses plaque formation assays confirmed these findings and demonstrated that relatively to the Wuhan-Hu and Omicron SARS-CoV-2, Delta formed more plaques that were smaller in size. Introducing a single P681R point mutation within the Wuhan-Hu spike, or H681R within Omicron spike, restored fusion potential to similar levels observed for Delta spike. Conversely, a R681P point mutation within Delta spike efficiency abolished fusion potential. We conclude that over time, the efficiency of the third dose of the Pfizer vaccine against SARS CoV-2 is waned, and cannot neutralize Omicron. We further verify that the P681 position of the viral spike dictates fusogenicity and syncytia formation.

In late 2019, an emergent betacorinavirus, Severe Acute Respiratory Syndrome Coronavirus 2 45 (SARS-CoV-2) was identified in China and defined as the cause for severe respiratory COVID-19 46 disease in humans. Two years following this outbreak, it is clear that the pandemic is here to stay, 47 leading to about 4% mortality and causing global effects on economic and quality of life [1, 2] . 48

Efforts to minimize spread of the virus led to major efforts to develop and authorize two mRNA elicited protection against Omicron and its lineages, Israel has recently initiated a fourth boost that is 68 currently being evaluated for its efficiency and indicates a short-term protection against SARS CoV-69 2 variants with no boosting [41] [42] [43] . 70

While the involvement of mutations within the RBD of spike are extensively being investigated 71 for a role in antibody-neutralization and viral infectivity, the role of 681PRRAR/SV687 mutations 72 located at the S1/S2 boundary of spike and located within the Furin Cleavage Site (FCS) is less clear. 73

This polybasic motif is unique to SARS-CoV-2 and has been previously reported to promote viral 74 entry in a TMPRSS2 dependent. TMPRSS2 on the target cell surface and cathepsins B and L in 75 endosomes then cleave the S2′ site and activate the fusion machinery, depending on the relative 76 availability of these enzymes [44, 45] Omicron has been also reported to exhibit lower replication levels in lung and gut cells, and its spike 80 was less efficiently cleaved compared to Delta. These differences were mapped to the entry efficiency 81 of the virus to specific cell types and effectively correlated with higher cellular TMPRSS2 RNA 82 expression. Overall, Omicron spike inefficiently used TMPRSS2, which promotes cell entry through 83 plasma membrane fusion, with greater dependency on cell entry through the endocytic pathway. 84

Consistent with the inefficient S1/S2 cleavage and inability to use TMPRSS2, syncytium formation 85 by Omicron spike was impaired compared with the Delta spike. This inefficient spike cleavage of 86

Omicron with a shift in cellular tropism away from TMPRSS2-expressing cells, with implications for 87 altered pathogenesis [52] [53] [54] . 88

Here we tested the neutralization potential of sera drawn from individuals who were fully 89 vaccinated with a third dose of the Pfizer BNT162b2 vaccine -four months post dose administration 90 -against the Wuhan-Hu SARS CoV-2 pseudovirus or its Delta and Omicron variants. We show that 91 relative to the wild-type Wuhan-Hu SARS-CoV2 and its Delta variant, Omicron displayed a sharp 92 decrease in neutralization sensitivity, as well as elevated infectivity levels. Live virus infection plaque 93 assay confirmed that Delta variant formed more plaques, which were less unified in their size and 94 overall smaller when compared to the Wuhan-Hu and Omicron SARS CoV-2. We then investigated 95 the role of the P681 residue in the spike FCS in enhancing cell fusion and syncytia formation. We 96 imaged fusion syncytia formation between target cells expressing Wuhan-Hu, Delta, Omicron and 97 BA.2 spike proteins, either by a GFP-split system that monitored GFP expression as a measure of cell 98 fusion upon spike expression [46], or by following fusion of transduced cells that express two 99 different fluorescent proteins. While the Wuhan-Hu spike, that carries a P681, did not enhance 100 fusogenic activity and syncytia formation, cells expressing Delta-R681 spike efficiently enhanced 101 fusion and syncytia formation between target cells. Introducing a single P681R mutation in the spike 102 of Wuhan-Hu-SARS-CoV-2, restored fusogenic potential and enhanced syncytia formation of this 103 spike. Parallelly, expression of Delta-spike protein carrying a single R681P mutation, abolished 104 fusion potential and syncytia formation. Omicron spike, that exhibits a P681H also displayed low 105 levels of fusion potential and syncytia formation -similar to those of the Wuhan-Hu spike. 106

Introducing an H681R in spike of Omicron, restored cell fusion potential and enhanced syncytia 107 formation, similar to those exhibited by Delta SARS-CoV-2. We therefore conclude that the P681 108 position of spike is critical for mediating cell fusion and syncytia formation.

Virus and viral culture 111 SARS-CoV-2 Delta and Omicron variants were isolated from the combined nasopharyngeal throat 112 swab of a COVID-19 patient in Israel. The viral culture was performed in a biosafety level 3 facility 113 as we described previously. Briefly, TMPRSS2-expressing VeroE6 (VeroE6/TMPRSS2) cells (JCRB 114 Cat # JCRB1819) were seeded with 100 μL of minimum essential medium (MEM) (Thermo Fisher 115 Scientific) at 4 × 10 4 cells in a 96-well plate and incubated at 37°C in a carbon dioxide incubator until 116 confluence for inoculation. Each well was inoculated with 30 μL of clinical specimen. The virus-117 induced cytopathic effect was examined. Cultures with more than 50% virus-induced cytopathic 118 effect were expanded to large volume, and 50% tissue culture infective dose (TCID50) was 119 determined. The whole-genome sequence of the culture isolates was confirmed using nanopore 120 sequencing as we described previously 121 122

For cell-cell fusion measurements, Vero-E6 cells stably expressing GFP1-10 and GFP11 were co-124 cultured at a 1:1 ratio and were transfected with a total of 1µg of phCMV-SARS-CoV2-Spike with 125

TransIT-X2 (Mirus) in a 24-well plate. At 24 h post-transfection, GFP fluorescence images were 126 documented using Olympus IX73. The GFP area and number of nuclei were quantified using ImageJ 127 software. Fusion was defined as percentage of GFP pixels. Results 211

We acquired blood samples from a cohort of individuals who were fully vaccinated with the third 214 dose of the BNT162b2 Pfizer vaccine. Sera was drawn four months post administration of the third 215 dose (n=20). Our cohort was tested for neutralizing potential against the original Wuhan-Hu SARS 216

CoV-2, its Delta and Omicron variants. We show that relative to the Wuhan-Hu SARS-CoV-2 217 pseudovirus, Omicron exhibited a x26 fold decrease in its neutralization sensitivity to the tested post-218 vaccinated sera ( Figure 1A) . Omicron also exhibited a x13 fold decrease in neutralization sensitivity 219 relative to the Delta pseudovirus. We also monitored the infectivity levels of the Omicron and Delta 220 variants relative to the wild type Wuhan-Hu pseudovirus. Omicron was x5 fold more infective than 221 the Wuhan-Hu SARS CoV-2. Moreover, we confirmed previous data reporting a x2-3 fold increase 222

in Delta variant infectivity relative to the wild type SARS CoV-2 pseudovirus (Figure 1B) 

The ability of the Wuhan-Hu SARS CoV-2 or its Delta and Omicron variants to induce cell-cell 252 fusion and syncytium formation was also monitored using live viruses. We envisioned that poor 253 fusion ability will impair viral infection through cell-cell contact. We therefore monitored plaque 254 formation and size by employing plaque assays with live viruses. Following infection, cultures were 255 layered with growth medium containing a semi-solid agarose, which inhibits cell-free infection and 256 viral spread, favoring cell-cell infection. Infected cells were then incubated at 33°C, fixed with 4% 257 PFA and washed before staining with Gentian Violet, which stains cells. Our assay showed that 258

Wuhan-Hu and Omicron viruses exhibited similar plaques morphology, which were different than 259 those of Delta. Delta formed more plaques than Wuhan-Hu and Omicron, which were less unified in 260 their morphology and smaller in their size. These results indicate that in a semi-fluid medium that 261 limits cell-free viral spread, Delta still can form plaques via cell-cell interaction and syncytia 262 formation (Figure 3) . this study, we used pseudoviruses and monitored the neutralization potential of a cohort of sera drawn 292 from fully vaccinated individuals -four months after third dose against the Wuhan-Hu SARS CoV-293 2 and its Delta and Omicron variants (Figure 1) . We show that, relative to wild-type Wuhan-Hu 294 pseudovirus, the efficiency of our samples to neutralize Omicron was substantially reduced -x26 295 fold. Furthermore, a decrease in the tested sera to neutralize the Delta pseudovirus was also reduced 296 x13 fold relative to the Wuhan-Hu SARS CoV-2. We also demonstrated that one of the main drivers 297 for this neutralization decrease was an enhanced infectivity level of Omicron, which was x5 fold 298 higher than the Wuhan-Hu pseudovirus (Figure 1) . Overall, we can conclude that over time, the 299 efficiency of the vaccine-elicited immune response is waned, rising major concerns regarding the 300 protection this vaccine provides against the Omicron variant and the need for an additional dose. 301

We further investigated the effects of mutations at position 681 polybasic region within the 302 FCS that appear in different circulating variants on fusion potential and syncytia formation of cells 303 expressing the spike protein. When expressed in Vero target cells, our data show that Wuhan-Hu and 304

Omicron spike proteins promote modest levels of fusion potential and syncytia formation (Figure 2) . 305

In contrast, the spike of the Delta efficiently promoted enhanced cell fusion and generated large 306 syncytia between target cells (Figure 2) . Our transit expression experiments were also confirmed 307 with live viruses, demonstrating that Delta forms different size plaques which are higher in numbers 308 when compared to Omicron and Wuhan-Hu (Figure 3) . Furthermore, the P681 residue has been 309 mapped as critical for the fusogenic activity of the different spike proteins. Changing P681 in the 310 Wuhan-Hu spike into R681 seen in Delta, restored fusogenicity and syncytia formation. Similarly 311 changing R681 of the Delta spike into P681 or H681 positioned within spike of Wuhan-Hu or 312

Omicron, abolished the fusion phenotype seen in Delta spike (Figure 4) . 313

The polybasic PRRAR motif is unique in the spike of SARS CoV-2. However, its functional 314 significance for viral infection is still debatable. Recent work has confirmed that this region is 315 important for viral transmission as it provides an evolutionary advantage for the virus to enter its 316 target cells at the cell surface by promoting membrane fusion between the virus and the cell and 317 between infected cells [49, 50, 65, 66] . Such syncytia potentially facilitate viral replication, 318 dissemination and immune evasion, causing cytopathic effects and wider tissue damage. In this 319 scenario, the virus successfully evades the innate IFITM2 response upon entry and efficiently spreads 320 [45, 51, 67] . On the other hand, in viruses that lack the polybasic PRRAR-region, viral entry is 321 mediated through endosomes, and therefore exposed to the IFITM2-innate anti-viral response. In 322 Vero E6 cells, that do not express the TMPRSS2 protease and lack of innate response, SARS-CoV-2 323 deleted FCS gain an advantage, potentially because there is an increase in its spike stability, and 324 premature shedding of the S1 subunit that abrogates receptor binding [68] . Knockout of TMPRSS2 325 or deletion of the poly-basic sequences, allows SARS-CoV-2 to mediate viral entry in a pH-326 independent manner, in part to mitigate against IFITM-mediated restriction and promote replication 327 and transmission [51] . FCS deletion also results in impaired infection, which is due to low viral titers 328 that are shed from an infected ferrets animal model, resulting in reduced transmission to cohoused 329 sentinel animals [45] . This report also showed that the TMPRSS2-mediated entry is more efficient in Vero-GFP 10 and 11 represent cells that express each of the GFP subunit. GFP expression is 406 restored only upon cell fusion that is dependent on SARS-CoV-2 spike. 407

Vero-E6-GFP split were transfected with the indicated spike proteins from Wuhan-Hu, Delta 408 BA.2 and Omicron. 48 h post transfection cells were imaged for their GFP expression as a 409 measurement for cell fusion. 

A pneumonia outbreak associated with a new 444 coronavirus of probable bat origin

A Novel Coronavirus from Patients with Pneumonia in 446 China

Potent neutralizing antibodies from 448 COVID-19 patients define multiple targets of vulnerability

A Neutralizing Monoclonal Antibody for 450 Hospitalized Patients with Covid-19

Isolation of potent SARS-CoV-2 neutralizing 452 antibodies and protection from disease in a small animal model

A noncompeting pair of human neutralizing antibodies block 454 COVID-19 virus binding to its receptor ACE2

A Potently Neutralizing Antibody Protects Mice 456 against SARS-CoV-2 Infection

Evolution of antibody immunity to SARS-CoV-2. 458

Safety and Immunogenicity of Two RNA-460 Based Covid-19 Vaccine Candidates

Safety and Efficacy of the BNT162b2 mRNA 462 Covid-19 Vaccine

Safety and Immunogenicity of SARS-CoV-464 2 mRNA-1273 Vaccine in Older Adults

SARS-CoV-2 vaccines in development

Efficacy and Safety of the mRNA

CoV-2 Vaccine

Safety and Efficacy of the BNT162b2 mRNA 469

Covid-19 Vaccine through 6 Months

Tracking Changes in SARS-CoV-2 Spike: 471 Evidence that D614G Increases Infectivity of the COVID-19 Virus

Spike mutation D614G alters SARS-CoV-2 fitness

SARS-CoV-2 D614G variant exhibits efficient 476 replication ex vivo and transmission in vivo

Complete Mapping of Mutations to the SARS-478

CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Escape from neutralizing antibodies by SARS-481

CoV-2 spike protein variants

Antibody cocktail to SARS-CoV-2 spike protein 483 prevents rapid mutational escape seen with individual antibodies

Molecular determinants and mechanism for antibody 486 cocktail preventing SARS-CoV-2 escape

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and 488 N501Y variants by BNT162b2 vaccine-elicited sera

Early transmission of SARS-CoV-2 in South 490

Africa: An epidemiological and phylogenetic report

Sixteen novel lineages of SARS-CoV-2 in 492 South Africa

Neutralization of SARS-CoV-2 lineage B.1.1.7 494 pseudovirus by BNT162b2 vaccine-elicited human sera

Resurgence of COVID-19 in Manaus, Brazil, 496 despite high seroprevalence

Evolution and epidemic spread of SARS-498

CoV-2 in Brazil

Neutralization of SARS-CoV-2 Variants B.1.429 and 500 B.1.351

Neutralization potential of Covishield 502 vaccinated individuals sera against B.1.617.1

Preliminary report on severe acute 504 respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K

SARS CoV-2 Delta variant exhibits enhanced 507 infectivity and a minor decrease in neutralization sensitivity to convalescent or post-508 vaccination sera

Protection of BNT162b2 Vaccine Booster 510 against Covid-19 in Israel

SARS-CoV-2 Omicron Variant 512 Neutralization in Serum from Vaccinated and Convalescent Persons

Omicron extensively but incompletely escapes 514

Pfizer BNT162b2 neutralization

Increased risk of SARS-CoV-2 516 reinfection associated with emergence of the Omicron variant in South Africa

Neutralization of SARS-CoV-2 Omicron variant by sera 519 from BNT162b2 or Coronavac vaccine recipients

Neutralizing antibodies against the SARS-521

CoV-2 Omicron variant following homologous and heterologous CoronaVac or BNT162b2 522 vaccination

mRNA-based COVID-19 vaccine 524 boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

SARS-CoV-2 Omicron-B. 1.1. 529 leads to 526 widespread escape from neutralizing antibody responses

The Omicron variant is highly resistant against 528 antibody-mediated neutralization-implications for control of the COVID-19 pandemic

Protection by a Fourth Dose of BNT162b2 531 against Omicron in Israel

Efficacy of a Fourth Dose of Covid-19 mRNA 533 Vaccine against Omicron

Fourth Dose of BNT162b2 mRNA Covid-535 19 Vaccine in a Nationwide Setting

SARS-CoV-2 Cell Entry Depends on 537 ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

The furin cleavage site in the SARS-CoV-2 spike 540 protein is required for transmission in ferrets

SARS-CoV-2 Alpha, Beta, and Delta variants 542 display enhanced Spike-mediated syncytia formation

Enhanced fusogenicity and pathogenicity of SARS-CoV-544

Delta P681R mutation

Opposing activities of IFITM proteins in SARS-546

CoV-2 infection

Syncytia formation by SARS-CoV-2-infected 548 cells

Syncytia formation by SARS-CoV-2-infected 550 cells

The Polybasic Cleavage Site in SARS-CoV-2 552

Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2

SARS-CoV-2 Omicron variant shows less efficient 554 replication and fusion activity when compared with Delta variant in TMPRSS2-expressed 555 cells

Attenuated fusogenicity and pathogenicity of 557 SARS-CoV-2 Omicron variant

Altered TMPRSS2 usage by SARS-CoV-2 Omicron 559 impacts tropism and fusogenicity

Genome-wide CRISPR knockout screen 561 identifies ZNF304 as a silencer of HIV transcription that promotes viral latency

scikit-image: image processing 564 in Python

SciPy 1.0: fundamental algorithms for 566 scientific computing in Python

Matplotlib: A 2D graphics environment

Array programming with NumPy

Virus-Mediated Cell-Cell Fusion

The Mechanism and Consequences of 573 SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation

Syncytia formation during SARS-CoV-2 lung infection: a 575 disastrous unity to eliminate lymphocytes

Persistence of viral RNA, pneumocyte syncytia 577 and thrombosis are hallmarks of advanced COVID-19 pathology

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 579 spike-induced syncytia

Loss of furin cleavage site attenuates SARS-CoV-581 2 pathogenesis

Attenuated SARS-CoV-2 variants with deletions at the 583 S1/S2 junction

Evolution of enhanced innate immune 585 evasion by SARS-CoV-2

SARS-CoV-2 spike-protein D614G mutation 587 increases virion spike density and infectivity

Enhanced fusogenicity and pathogenicity of SARS-CoV-589

Delta P681R mutation

B.1.617.2 enters and fuses lung cells with 591 increased efficiency and evades antibodies induced by infection and vaccination

Membrane fusion and immune evasion by the spike protein 594 of SARS-CoV-2 Delta variant